This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Fonar Corp
FONR : NASDAQ : Health Care
$14.49 up0.76 | 5.54%
Today's Range: 13.78 - 15.00
Avg. Daily Volume: 28,500
10/06/15 - 4:00 PM ET

Financial Analysis

FONAR CORP's gross profit margin for the fourth quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Even though sales decreased, the net income has increased, representing an increase to the bottom line. FONAR CORP is extremely liquid. Currently, the Quick Ratio is 2.12 which clearly shows the ability to cover any short-term cash needs. The company managed to increase its liquidity from the same period a year ago, despite already having strong liquidity to begin with. This would indicate improved cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 51.67% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q4 FY15 Q4 FY14
Net Sales ($mil)16.8817.03
EBITDA ($mil)4.083.56
EBIT ($mil)3.22.63
Net Income ($mil)5.74.08

Balance Sheet Q4 FY15 Q4 FY14
Cash & Equiv. ($mil)9.459.95
Total Assets ($mil)76.4976.79
Total Debt ($mil)8.1911.37
Equity ($mil)38.3925.31

Profitability Q4 FY15 Q4 FY14
Gross Profit Margin47.7550.54
EBITDA Margin24.1520.93
Operating Margin18.9415.47
Sales Turnover0.90.89
Return on Assets16.8713.53
Return on Equity33.6241.07
Debt Q4 FY15 Q4 FY14
Current Ratio2.322.02
Interest Expense0.160.2
Interest Coverage20.3612.98

Share Data Q4 FY15 Q4 FY14
Shares outstanding (mil)6.436.43
Div / share0.00.0
Book value / share5.973.94
Institutional Own % n/a n/a
Avg Daily Volume28597.021835.0


BUY. FONAR CORP's P/E ratio indicates a significant discount compared to an average of 33.47 for the Health Care Equipment & Supplies industry and a significant discount compared to the S&P 500 average of 19.38. To use another comparison, its price-to-book ratio of 2.24 indicates a discount versus the S&P 500 average of 2.58 and a significant discount versus the industry average of 14.77. The price-to-sales ratio is below the S&P 500 average and is well below the industry average, indicating a discount. Upon assessment of these and other key valuation criteria, FONAR CORP proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
FONR 6.84 Peers 33.47   FONR 6.47 Peers 24.35

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

FONR is trading at a significant discount to its peers.


Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

FONR is trading at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
FONR NA Peers 22.74   FONR NA Peers 0.78

Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.

Ratio not available.


Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
FONR 2.24 Peers 14.77   FONR 23.41 Peers 7.03

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

FONR is trading at a significant discount to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

FONR is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
FONR 1.24 Peers 5.44   FONR 0.79 Peers 14.15

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

FONR is trading at a significant discount to its industry on this measurement.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

FONR significantly trails its peers on the basis of sales growth



Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Real Money
Try it NOW

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs